Dr. Gordon, one concern I've heard expressed is one of potential bias.
In May 2023, before the expedited review of the current guidelines had even started, Dr. Guylène Thériault, co-chair of the Canadian Task Force on Preventative Health Care, told the Toronto Star that she does not see any reason to change the task force's guidelines on breast screening, which means to keep it at the current age of 50. In addition, just this month, Dr. Thériault co-authored a journal article called “Debunking myths about screening”.
As a scientist, researcher and someone involved in this, what kind of confidence or lack of confidence does this give you that Dr. Thériault is able to fairly adjudicate based on the evidence?